Ruslan Medzhitov, PhD

Yale University School of Medicine
Howard Hughes Medical Institute


Ruslan Medzhitov joined the Yale faculty in 1999 and is currently a Sterling Professor at Yale University School of Medicine and an Investigator of the Howard Hughes Medical Institute.  He discovered the first mammalian Toll-like receptor and demonstrated the essential role of innate immune recognition in the control of adaptive immune responses, which is one of the fundamental paradigms of modern immunology. His current research interests include biology of inflammation, allergy, biological bases of diseases and evolutionary design of biological systems.

Dr. Medzhitov is a director of Food Allergy Science Initiative at the Broad Institute. He serves on the editorial boards of several scientific journals, on the Scientific Advisory Board of the IMP Institute, Vienna, on the National Advisory Board of the PEW Scholars Program, The Scientific Advisory Board of SABRE-Sandler Asthma Basic Research Center, and on a Review Board of the Crick Institute, London.

Dr. Medzhitov is a member of the National Academy of Sciences and the National Academy of Medicine. He is a member of the European Molecular Biology Organization, a fellow of the American Academy of Microbiology and a foreign member of the Russian Academy of Sciences.

His awards include William B. Coley Award, Cancer Research Institute, 2003; Emil von Behring Award, 2004; AAI–BD Biosciences Investigator Award, 2006; Blavatnik Award for Young Scientists, 2007; Howard Taylor Ricketts Award, The University of Chicago, 2008; Lewis S. Rosenstiel Award, Brandeis University, 2010; The Shaw Prize in Life Science and Medicine, 2011; Vilcek Prize, New York, 2013; Lurie Prize, Chicago, 2013; Else Kröner Fresenius Stiftung Prize, Germany, 2013; and the Charles W. Bohmfalk Teaching Prize, 2015.